In the following paragraphs we will describe the cellular functional derangements associated with the LQTS and CPVT phenotypes and address, as much as current knowledge allows, the mechanisms underlying target specificity of CaM mutations. The gene discussed is CALM1; the disease is catecholaminergic polymorphic ventricular tachycardia.